BOSTON, Nov. 8, 2021 /PRNewswire/ -- Today, Ginkgo Bioworks (NYSE: DNA), the leading horizontal platform for cell programming, announced that it plans to host a presentation and Q&A session reviewing business performance for the third quarter ended September 30, 2021, on Monday, November 15, 2021, beginning at 8:00 a.m. ET.
The presentation details and registration link will be available on Ginkgo's investor relations website at www.ginkgobioworks.com/investors and a replay will be made available.
About Ginkgo Bioworks
Ginkgo is building a platform to enable customers to program cells as easily as we can program computers. The company's platform is enabling biotechnology applications across diverse markets, from food and agriculture to industrial chemicals to pharmaceuticals. Ginkgo has also actively supported a number of COVID-19 response efforts, including K-12 pooled testing, vaccine manufacturing optimization and therapeutics discovery. For more information, visit www.ginkgobioworks.com.
Ginkgo Bioworks Contacts:
SOURCE Ginkgo Bioworks